These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 34702338)

  • 21. 'I went for rehab many times and it never worked, but the harm reduction process has given me renewed hope'. Perceptions on the effectiveness of harm reduction and community-based opioid substitution therapy.
    Nyashanu T; Scheibe A; Visser M
    Health Promot J Austr; 2024 Jul; 35(3):653-661. PubMed ID: 37605794
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Experiences of stigma in hospitals with addiction consultation services: A qualitative analysis of patients' and hospital-based providers' perspectives.
    Hoover K; Lockhart S; Callister C; Holtrop JS; Calcaterra SL
    J Subst Abuse Treat; 2022 Jul; 138():108708. PubMed ID: 34991950
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Opioid substitution treatment in pretrial prison detention: a case study from Geneva, Switzerland.
    Favrod-Coune T; Baroudi M; Casillas A; Rieder JP; Gétaz L; Barro J; Gaspoz JM; Broers B; Wolff H
    Swiss Med Wkly; 2013; 143():w13898. PubMed ID: 24186493
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Consumer and treatment provider perspectives on reducing barriers to opioid substitution treatment and improving treatment attractiveness.
    Deering DEA; Sheridan J; Sellman JD; Adamson SJ; Pooley S; Robertson R; Henderson C
    Addict Behav; 2011 Jun; 36(6):636-642. PubMed ID: 21276664
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Opioids substitution therapy: A respect for the dignity of the human person].
    Richa S; Dirani E; Lucet C; Laqueille X
    Encephale; 2022 Jun; 48(3):351-353. PubMed ID: 34583830
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Perceptions and experiences of patients attending an opioid substitution clinic in South Africa.
    Domingo AK; Pasche S; Jarvis L; Weich L
    S Afr J Psychiatr; 2022; 28():1936. PubMed ID: 36569808
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Screening for breast and cervical cancer among OST patients: a qualitative study of barriers and suggested interventions to increase participation.
    Garpenhag L; Dahlman D
    Int J Qual Stud Health Well-being; 2023 Dec; 18(1):2175767. PubMed ID: 36756664
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Differences in polysubstance use patterns and drug-related outcomes between people who inject drugs receiving and not receiving opioid substitution therapies.
    Betts KS; Chan G; McIlwraith F; Dietze P; Whittaker E; Burns L; Alati R
    Addiction; 2016 Jul; 111(7):1214-23. PubMed ID: 26857811
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Uptake and delivery of hepatitis C treatment in opiate substitution treatment: perceptions of clients and health professionals.
    Treloar C; Newland J; Rance J; Hopwood M
    J Viral Hepat; 2010 Dec; 17(12):839-44. PubMed ID: 20070504
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mortality of treatment-seeking men and women with alcohol, opioid or other substance use disorders - A register-based follow-up study.
    Pitkänen T; Kaskela T; Levola J
    Addict Behav; 2020 Jun; 105():106330. PubMed ID: 32088539
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Substance use and opioid-related stigma among Black communities in the rural South.
    Cody SL; Newman S; Bui C; Sharp-Marbury R; Scott L
    Arch Psychiatr Nurs; 2023 Oct; 46():127-132. PubMed ID: 37813495
    [TBL] [Abstract][Full Text] [Related]  

  • 32. 'Not just methadone Tracy': transformations in service-user identity following the introduction of hepatitis C treatment into Australian opiate substitution settings.
    Rance J; Treloar C;
    Addiction; 2014 Mar; 109(3):452-9. PubMed ID: 24678545
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Challenges to implementing opioid substitution therapy in Ukrainian prisons: Personnel attitudes toward addiction, treatment, and people with HIV/AIDS.
    Polonsky M; Azbel L; Wickersham JA; Taxman FS; Grishaev E; Dvoryak S; Altice FL
    Drug Alcohol Depend; 2015 Mar; 148():47-55. PubMed ID: 25620732
    [TBL] [Abstract][Full Text] [Related]  

  • 34. How to overcome hurdles in opiate substitution treatment? A qualitative study with general practitioners in Belgium.
    Fraeyman J; Symons L; Van Royen P; Van Hal G; Peremans L
    Eur J Gen Pract; 2016 Jun; 22(2):134-40. PubMed ID: 26799738
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Use of opioid substitution therapies in the treatment of opioid use disorder: results of a UK cost-effectiveness modelling study.
    Kenworthy J; Yi Y; Wright A; Brown J; Maria Madrigal A; Dunlop WCN
    J Med Econ; 2017 Jul; 20(7):740-748. PubMed ID: 28489467
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Exploring the Concepts of Abstinence and Recovery Through the Experiences of Long-Term Opiate Substitution Clients.
    Notley C; Blyth A; Maskrey V; Pinto H; Holland R
    Subst Abus; 2015; 36(2):232-9. PubMed ID: 25127184
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Understanding stigma through the lived experiences of people with opioid use disorder.
    Judd H; Yaugher AC; O'Shay S; Meier CL
    Drug Alcohol Depend; 2023 Aug; 249():110873. PubMed ID: 37390780
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Diversion of methadone and buprenorphine from opioid substitution treatment: a staff perspective.
    Johnson B; Richert T
    J Psychoactive Drugs; 2014; 46(5):427-35. PubMed ID: 25364995
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Facilitated telemedicine for hepatitis C virus: Addressing challenges for improving health and life for people with opioid use disorder.
    Talal AH; Jaanimägi U; Dharia A; Dickerson SS
    Health Expect; 2023 Dec; 26(6):2594-2607. PubMed ID: 37641398
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A meta-analysis on the effects of incarceration-based opioid substitution treatment.
    Boksán K; Dechant M; Weiss M; Hellwig A; Stemmler M
    Med Sci Law; 2023 Jan; 63(1):53-60. PubMed ID: 35934979
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.